The ultrasound probe disinfection market
was valued at USD 260.7 million in 2017 and is estimated to grow at a
CAGR of 21.1% during the forecast period, to reach USD 819.1 million by
2023.
Factors such as the increasing number of ultrasound
imaging procedures, rising incidence of hospital-acquired infections due
to the improper reprocessing of ultrasound probes, increasing adoption
of high-level disinfection systems for critical and semi-critical
ultrasound probes, and technological advancements in ultrasound probes
are driving the growth of this market.
Drivers
1 Increasing Number of Ultrasound Imaging Procedures
2 Rising Incidence of Hospital-Acquired Infections Due to Improper Reprocessing of Ultrasound Probes
3 Increasing Adoption of Automated High-Level Disinfection Systems for Critical and Semi-Critical Ultrasound Probes
4 Government Regulations and Guidelines in Developed Markets
5 Technological Advancements in Ultrasound Probes
Market Restraints
1 High Cost of Automated Probe Reprocessors
2 Reluctance to Shift From Manual Disinfection Methods to Automated Probe Reprocessors
Market Opportunities
1 Increasing Birth Rates/Number of Pregnancies
Market Challenges
1 Lack of Knowledge About Probe Reprocessing
2 Inadequate Cleaning and Disinfection of Probes
Geographically, the global ultrasound probe
disinfection market is segmented into North America, Europe, the Asia
Pacific, Latin America, and the Middle East and Africa. North America is
expected to account for the largest share of the market in 2018. Also,
this regional market is estimated to grow at the highest CAGR during the
forecast period. This can be attributed to the increasing number of
transvaginal, transrectal, abdominal, and intraoperative ultrasound
procedures; growing number of transesophageal echocardiography (TEE) and
ultrasound-guided interventional procedures (biopsies and venous
access); rising adoption of high-level disinfectants; and the presence
of leading market players in this region. However, the high cost of
automated probe reprocessors and the reluctance to shift from manual
disinfection methods to automated probe reprocessors are restraining the
growth of this market.
Nanosonics (Australia), CIVCO Medical Solutions (US),
and Tristel (UK) dominated the global ultrasound probe disinfection
market in 2017. Some of the other players competing in this market are
Ecolab (US), Germitec (France), Parker Laboratories (US), Schülke &
Mayr (Germany), CS Medical (US), Virox Technologies (Canada), STERIS
(UK), Advanced Sterilization Products (US), and Metrex Research (US).
Comments
Post a Comment